Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

Clinical Q&A

HepatologyViral hepatitis

Hepatitis C

Click a heading in the right-hand column to see the selected questions in that subject area

Please submit a new question (maximum 100 words) or any comments to QandA@GastroHep.com. Please make sure you include the title of the Q&A you are commenting on in the subject line of your email. Please note that this service is only for medically qualified professionals, and not for the general public. The questions should be based on a clinical problem. You may nominate the expert from our Global Academic Faculty whom you would like us to contact for the first reply. Don't forget to include your full name, city, country and your email address.

The patient is a 46-year-old man with compensated cirrhosis (Child's class A), which was diagnosed after needle biopsy during surgery for intestinal obstruction. He has normal PT, Alb, ALT, AST and platelet count. No esophageal varices were found. The liver histology report was grade = 4 stage = 6; HCV-RNA was positive. No quantification or genotype testing is available.

How should he be treated?

Peyamn Adibi, Tehran, Iran  
 

Answer 1: It is not clear what grading system is being used here (e.g. Ishak or Knodell) and which score refers to inflammation and which to fibrosis. However, it sounds as if there is significant fibrosis and therefore a good case for combined treatment with interferon and ribavirin.

IT Gilmore, London, England  

 

Answer 2: In a patient with compensated HCV cirrhosis, treatment with pegylated interferon and ribavirin is appropriate with duration dependent on genotype.

R Zetterman, Omaha, Nebraska, USA  

Please submit your comments about this answer to QandA@GastroHep.com.

DISCLAIMER: Clinical Q & A is for information only and is not a substitute for specific medical advice and diagnosis from a medical practitioner. Neither the content providers nor the publisher accept any legal responsibility for nor make any warranty with respect to the views expressed or procedures outlined on the site.

Go to top of page Email this page Email this page to a colleague

 22 September 2014

Advanced search
Close folder Gastroenterology
Mouth
Esophagus
Stomach & duodenum
Helicobacter pylori
Small intestine
Colo-rectum and anus
Pancreas
Inflammatory bowel disease
Functional bowel disorders
Nutrition
Symptoms/signs of gastrointestinal disease
Basic science
Close folder Hepatology
Biliary tract
  Viral hepatitis
Liver diseases
Cirrhosis and portal hypertension
Liver transplantation
Liver & other diseases
Pediatric hepatology
Basic science
Close folder Endoscopy
Upper endoscopy
ERCP
Colonoscopy
Endoscopic ultrasound
Technology
Practice issues

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us